Pages that link to "Q28345285"

The following pages link to Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor (Q28345285):

Displaying 49 items.

• LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells (Q28249874) (← links)
• Prostate cancer and the met hepatocyte growth factor receptor (Q28278555) (← links)
• PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion (Q28280290) (← links)
• A PAK6-IQGAP1 complex promotes disassembly of cell-cell adhesions (Q28304367) (← links)
• Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE) (Q28652074) (← links)
• Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells (Q30446159) (← links)
• Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells (Q30448859) (← links)
• Receptor tyrosine kinase Met promotes cell survival via kinase-independent maintenance of integrin α3β1 (Q30791975) (← links)
• Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607. (Q31062741) (← links)
• MCMDA: Matrix completion for MiRNA-disease association prediction (Q33591474) (← links)
• Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis. (Q33789808) (← links)
• High expression of the Met receptor in prostate cancer metastasis to bone (Q34163761) (← links)
• A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings (Q34185858) (← links)
• Gene transfer of α1,3‐fucosyltransferase increases tumor growth of the PC‐3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cells (Q34274788) (← links)
• Activation of the MEK-S6 pathway in high-grade ovarian cancers (Q34339010) (← links)
• Human prostate cancer risk factors (Q34360616) (← links)
• Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases. (Q35070139) (← links)
• Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostate (Q35084939) (← links)
• The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. (Q35224818) (← links)
• DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance. (Q35273434) (← links)
• Prostate Development and Carcinogenesis (Q35547017) (← links)
• Knockdown of WAVE3 impairs HGF induced migration and invasion of prostate cancer cells (Q35690865) (← links)
• The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression (Q36468996) (← links)
• Differences in phenotype and gene expression of prostate stromal cells from patients of varying ages and their influence on tumour formation by prostate epithelial cells (Q37085297) (← links)
• Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET. (Q37883394) (← links)
• Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer (Q37968256) (← links)
• Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression (Q38298477) (← links)
• Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells (Q38311224) (← links)
• Negative acting HLH proteins Id 1, Id 2, Id 3, and Id 4 are expressed in prostate epithelial cells (Q38330495) (← links)
• Differential Redox Regulation of Ca²⁺ Signaling and Viability in Normal and Malignant Prostate Cells. (Q38829680) (← links)
• ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer (Q39062491) (← links)
• Intracellular signaling cascades triggered by the NK1 fragment of hepatocyte growth factor in human prostate epithelial cell line PNT1A (Q39503087) (← links)
• Prostate cancer‐derived angiogenin stimulates the invasion of prostate fibroblasts (Q39585995) (← links)
• Inhibitor of differentiation 1 (ID1) promotes cell survival and proliferation of prostate epithelial cells (Q39734867) (← links)
• Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering (Q40364403) (← links)
• Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progression (Q40419581) (← links)
• Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c. (Q40464303) (← links)
• Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy (Q41977380) (← links)
• Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death (Q41998434) (← links)
• Basal prostate epithelial cells stimulate the migration of prostate cancer cells (Q42467887) (← links)
• Regulation of cell proliferation in a stratified culture system of epithelial cells from prostate tissue (Q42492547) (← links)
• Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events (Q45076750) (← links)
• Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA). (Q47887528) (← links)
• Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis (Q50899921) (← links)
• A Novel Model for Predicting Associations between Diseases and LncRNA-miRNA Pairs Based on a Newly Constructed Bipartite Network. (Q55101006) (← links)
• Integrating random walk and binary regression to identify novel miRNA-disease association (Q61807715) (← links)
• A Novel Method for Predicting Disease-Associated LncRNA-MiRNA Pairs Based on the Higher-Order Orthogonal Iteration. (Q64969464) (← links)
• TLHNMDA: Triple Layer Heterogeneous Network Based Inference for MiRNA-Disease Association Prediction (Q90297877) (← links)
• Centrosome loss results in an unstable genome and malignant prostate tumors (Q93064621) (← links)